Category: Latest Update

A controlled lab study led by Mote Marine Laboratory and published June 1 in the peer-reviewed journal PLOS ONE revealed that black band disease was less deadly to mountainous star

“We found approximately 90% of all the species of mammals expected for São Paulo State,” Galetti said. “Animals living in these fragments include the jaguar (Panthera onca), giant anteater (Myrmecophaga

CHICAGO — About 50% of all cancer survivors and 70% of young breast cancer survivors report moderate to high fear of recurrence. The fear can be so distressing that it

The W-band covers the frequencies used by automotive radars. Sophisticated driver-assistance and selfdriving will require radars with millimeter-wave beam scanning capability that can “see” day and night and even in

Mutations in the RAS gene account for more than 90 percent of pancreatic cancers, 50 percent of colorectal cancers, and 30 percent of lung cancers, and a significant portion of

Splitting a water molecule requires a metal catalyst to get the reaction going. Recently, much scientific attention has focused on cobalt, a relatively abundant and inexpensive catalyst that — in

Preliminary results show that newborns of mothers with sleep apnea were more likely to be admitted to the intensive care unit (25.3% vs. 8.1%) or special care nursery (34.9% vs.

Symptoms are common among patients receiving treatment for advanced cancers, yet are undetected by clinicians up to half the time. There is growing interest in integrating electronic patient-reported outcomes (PROs)

Results show that the total rate of clinical agreement between the patch and standard in-lab polysomnography was 87.4 percent with 95 percent confidence interval of 81.4 percent to 91.9 percent.

“Although previous studies suggested olaparib could benefit patients with advanced breast cancers, we are now reporting that olaparib improves profession-free survival better than standard chemotherapy,” said study co-author Susan Domchek,

Results show that 74 percent of partners encouraged an early bedtime or late wake time, which is in direct conflict with the principles of cognitive behavioral therapy for insomnia (CBTI).

The trial investigated the drug in two separate cohorts of patients: Cohort A, which included 170 patients with heavily pretreated metastatic triple negative breast cancer (mTNBC) regardless of PD-L1 expression,

The results from the Cancer Research UK-funded STAMPEDE trial could change the standard of care for men with prostate cancer, making abiraterone a first-line treatment alongside hormone therapy. This part

C-sections account for around a quarter of all births in the UK, USA, and Canada. Chronic pain (lasting for more than 3 months) after C-section affects around 1 in 5